** Shares of medical device maker Zimmer Biomet Holdings ZBH.N rise 1.5% to $103.87 premarket
** ZBH posts Q1 adj. profit of $1.81 per share, beating analysts' estimate of $1.77 per share, according to data compiled by LSEG
** Company reports Q1 revenue of $1.91 billion vs estimates of $1.90 billion
** Company cuts its annual adj profit forecast to a range of $7.9 and $8.1 per share, compared with previously projected adj profit forecast of $8.15 to $8.35 per share
** However, ZBH expects 2025 revenue growth to be 5.7% to 8.2% including co's acquisition of orthopedic surgical devices maker Paragon 28 7GQ.F, currency and current tariff impact
** As of last close, ZBH has fallen 3.1% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。